Concord Biotech IPO Description – Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology, supplying 200 customers in over 70 countries including regulated markets, such as the United States, Europe, and Japan, and India.
As of 31 March 2022, Concord Biotech had six fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus. It had a total annual installed fermentation capacity for APIs of 1,250 m3 cubic meters. It has established two DSIR (Department of Science & Industrial Research)-approved R&D units with 163 members.
The company operates three manufacturing facilities in Gujarat, India, comprising API manufacturing facilities in Dholka and Limbasi and a formulation manufacturing facility in Valthera.
Promoters of Concord Biotech – Sudhir Vaid and Ankur Vaid
Concord Biotech IPO Details
| Concord Biotech IPO Dates | 4 – 8 August 2023 |
| Concord Biotech IPO Price | INR 705 – 741 per share Employee Discount – INR 70 per share |
| Fresh issue | NA |
| Offer For Sale | 20,925,652 shares (INR 1,475.26 – 1,550.52 crore) |
| Total IPO size | 20,925,652 shares (INR 1,475.26 – 1,550.52 crore) |
| Minimum bid (lot size) | 20 shares (INR 14,820) |
| Face Value | INR 1 per share |
| Retail Allocation | 35% |
| Listing On | BSE, NSE |
Concord Biotech Financial Performance
| Â | FY 2021 | FY 2022 | FY 2023 |
| Revenue | 616.94 | 712.93 | 853.17 |
| Expenses | 317.58 | 495.19 | 568.42 |
| Net income | 234.89 | 174.93 | 240.08 |
| Margin (%) | 38.07 | 24.54 | 28.14 |
Concord Biotech Offer News
- Concord Biotech RHP
- Concord Biotech DRHP
- Concord Biotech IPO Ratings: Brokers Upbeat About Prospects
- Concord Biotech IPO Review: A Deep Dive into Biopharma Player’s Business
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Concord Biotech Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 22.45 | 16.72 | 22.95 |
| PE ratio | – | – | 30.72 – 32.29 |
| RONW (%) | 26.55 | 16.64 | 20.06 |
| NAV | 95.53 | 105.45 | 123.31 |
| ROCE (%) | 28.54 | 20.55 | 24.27 |
| EBITDA (%) | 53.02 | 37.82 | 40.47 |
| Debt/Equity | 0.09 | 0.05 | 0.02 |
Concord Biotech IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 17 August 2023 | 110 | 650 | 1,800 |
| 16 August 2023 | 110 | 650 | 1,800 |
| 14 August 2023 | 150 | 700 | 2,000 |
| 12 August 2023 | 150 | 700 | 2,000 |
| 11 August 2023 | 155 | 700 | 2,000 |
| 10 August 2023 | 150 | 700 | 2,000 |
| 9 August 2023 | 140 | 650 | 2,000 |
| 8 August 2023 | 160 | 700 | 2,500 |
| 7 August 2023 | 180 | 680 | 2,800 |
| 5 August 2023 | 180 | 650 | 2,800 |
| 4 August 2023 | 170 | 600 | 2,700 |
| 3 August 2023 | 170 | 550 | 2,500 |
| 2 August 2023 | 220 | 600 | 3,000 |
| 1 August 2023 | 250 | 700 | 4,000 |
| 31 July 2023 | 300 | – | – |
Concord Biotech IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| Shares Offered | 41,83,130 | 31,37,348 | 73,20,479 | 10,000 | 1,46,50,957 |
| 8 Aug 2023 | 67.67 | 16.99 | 3.78 | 24.47 | 24.86 |
| 7 Aug 2023 | 1.61 | 5.22 | 2.26 | 15.68 | 2.72 |
| 4 Aug 2023 | 0.01 | 1.01 | 0.72 | 5.73 | 0.58 |
Concord Biotech IPO Allotment Status
Concord Biotech IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.
Meanwhile, bank debits and lien removal have started. Check effective bank balance to get allotment status.
Concord Biotech IPO Dates & Listing Performance
| Concord Biotech IPO Opening Date | 4 August 2023 |
| Concord Biotech IPO Closing Date | 8 August 2023 |
| Finalization of Basis of Allotment | 11 August 2023 |
| Initiation of refunds | 14 August 2023 |
| Transfer of shares to demat accounts | 17 August 2023 |
| Concord Biotech IPO Listing Date | 18 August 2023 |
| Opening Price on NSE | INR 900.05 per share (up 21.46%) |
| Closing Price on NSE | INR 942.80 per share (up 27.23%) |
Concord Biotech IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Antique Stock Broking –
Arihant Capital –
Ashika Research – Not Rated
Asit C Mehta –
BP Wealth – Avoid
Canara Bank Securities – Subscribe for long term
Choice Broking – Subscribe
Dalal & Broacha –
Elite Wealth – Subscribe
GCL Broking –
Geojit –
GEPL Capital – Subscribe
Hem Securities – Subscribe
INVESTMENTZ – Subscribe
ICICIdirect –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Nirmal Bang –
Reliance Securities –
Religare Broking –
Systematix PCG Research – Not Rated
Samco Securities – Subscribe for Long term
SMC Global – 2/5
Swastika Investmart –
Ventura Securities –
Concord Biotech Offer Lead Manager
KOTAK MAHINDRA CAPITAL COMPANY LIMITED
27BKC, 1st Floor, Plot no. C-27,
‘G’ Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051
Phone: +91 22 4336 0000
Email:Â [email protected]
Website: www.investmentbank.kotak.com
Concord Biotech Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park, L.B.S. Marg,
Vikhroli (West), Mumbai – 400083, Maharashtra
Phone: +91 22 49186200
E-mail:Â [email protected]
Website:Â www.linkintime.co.in
Concord Biotech Contact Details
CONCORD BIOTECH LIMITED
16th floor, B-Wing, Mondeal Heights,
Iscon Cross Road, S.G. Highway, Ahmedabad – 380015
Phone:Â 079-6813 8700
Email:Â [email protected]
Website: www.concordbiotech.com
Concord Biotech IPO FAQs
How many shares in Concord Biotech IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply in Concord Biotech Public Offer?
The best way to apply in Concord Biotech public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Concord Biotech IPO GMP today?
Concord Biotech IPO GMP today is INR 150 per share.
What is Concord Biotech kostak rate today?
Concord Biotech kostak rate today is INR 650 per application.
What is Concord Biotech Subject to Sauda rate today?
Concord Biotech Subject to Sauda rate today is INR1,800 per application.
